News

Worldwide Clinical Trials adds cutting-edge AI tool, powered by NetraMark, into its services to enhance clinical trial ...
CNW/ - NetraMark Holdings Inc. (the "Company" or "NetraMark") (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier ...
DeepSolar's product, MyDeepSolar, is an application that leverages machine learning and predictive analytics to provide ...
Financial decision-making is undergoing a transformation, thanks to artificial intelligence (AI) and its rapid advancements in predictive modeling. Iswarya Konasani, an expert in AI-driven risk ...
RedChip Companies will air interviews with Bullfrog AI Holdings, Inc. (Nasdaq:BFRG) and Connect Biopharma Holdings Limited ...
This collaboration with Intrinseque Health allows us to introduce AI-driven logistics automation and real-time supply optimization, making clinical trial execution more predictable and cost ...
As oncology research centers scale eSource adoption, the field is shifting toward a fully digital, clinical trial ecosystem.
the optimization of clinical trials by uncovering hidden patient subpopulations, the application of NetraMark's AI technology in Phase 2 and select Phase 3 clinical trials, the integration of ...